NIAID Site Search

NIAID scientists determined the high-resolution 3D structure of an Epstein-Barr virus (EBV) surface protein in complex with its receptor, revealing a key site of vulnerability that could lead to much-needed interventions against this common human pathogen.

Published: March 4, 2025

For decades, scientists have wondered how different strains of prions can propagate when they do not carry their own genes with them as they move from host to host. A new study from NIAID researchers and colleagues reveals how differences in the folding of the primary protein of prions (PrP) can help determine the distinct characteristics of prion strains.

Published: July 13, 2022

Lenette Lu, M.D., Ph.D., of the Massachusetts General Hospital K08 sample application

Last Reviewed: March 31, 2025

Tuan Manh Tran, M.D., Ph.D., of the Indiana University-Purdue University at Indianapolis K08 sample application

Last Reviewed: March 31, 2025

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Immunology Interest Group (IIG) Newsletter November 2024

Last Reviewed: December 4, 2024

Sample application from Nicole Putnam, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: January 25, 2023

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: April 16, 2024

The Pathogenesis and Immunity Section conducts human and animal studies of malaria pathogenesis and host immunity, including population-based studies in communities exposed to Plasmodium falciparum. Our research emphasizes pregnant women and children, the populations most susceptible to malaria morbidity and mortality, with collaborative cohort studies ongoing in Mali, Liberia and Guinea.

Last Reviewed: October 3, 2022

Last Reviewed: August 6, 2024

Last Reviewed: November 24, 2023

Why do some people hospitalized with COVID-19 succumb, while others—with apparently similar disease severity at the time of hospitalization—survive? Among older individuals, are there particular immune responses to SARS-CoV-2 virus infection that set the stage for the increased risk of severe COVID-19? New publications from the NIAID-funded IMPACC study help provide answers.

Published: May 1, 2024

Jordan Report: Accelerated Development of Vaccines (2012) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2012

Expert articles from Jordan Report: Accelerated Development of Vaccines (2012) from NIAID

Last Reviewed: December 31, 2012

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Last Reviewed: November 24, 2023

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

Lead Institution: London School of Hygiene & Tropical Medicine Research Areas Despite a significant reduction in malaria morbidity and mortality in India, Plasmodium cases persist in the State of Odisha, hindering malaria control and elimination efforts locally and statewide. Through a community-based prospective cohort study, the India ICEMR investigates factors driving this maintenance of

Last Reviewed: August 23, 2024

Vector-Borne Diseases Systems Ecology in the Context of Climate Change: Understanding Transmission of Arthropod-Borne Pathogens Across Biological & Ecological Scales

Last Reviewed: September 1, 2023

Carrie Mae Long, Ph.D. is an Independent Research Scholar in the Coxiella Pathogenesis Section at NIAID. Our group seeks to gain a better understanding of bacterial and host factors involved in C. burnetii virulence. Additionally, we are focused on developing a “better” Q fever vaccine. The current Q fever vaccine is highly efficacious but can cause a post-vaccination hypersensitivity response.

Last Reviewed: December 6, 2024

Scientists have long been aware that malaria infection is associated with high levels of autoantibodies���antibodies that recognize and attack the person���s own tissues and are associated with autoimmune disorders. NIAID researchers, along with their colleagues, have studied the molecular mechanisms of these autoantibodies. Their findings reveal the associations between malaria, human resistance to it, and autoantibodies that are linked to certain autoimmune disorders���specifically, systemic lupus erythematosus (SLE).

Published: July 5, 2024

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), reaffirms our commitment to developing safe and effective medical tools against malaria, and, in the words of this year’s World Malaria Day theme, “Harnessing innovation to reducing the malaria disease burden and saving lives.”

Published: April 25, 2022

Sample application from Chad A. Rappleye, Ph.D., for a two-year small grant (R03).

Last Reviewed: November 29, 2022

Sample application from Rahul Raghavan, Ph.D., for Research Enhancement Award (R15) grant.

Last Reviewed: November 28, 2022

Sample application from Artem Domashevskiy, Ph.D., for Research Enhancement Award (R15) grant.

Last Reviewed: November 29, 2022